PremiumPre-EarningsXERS Earnings Report this Week: Is It a Buy, Ahead of Earnings? Xeris Biopharma price target raised to $5 from $4.50 at Craig-Hallum Xeris Biopharma reports Q2 EPS (10c), consensus (11c) PremiumCompany AnnouncementsXeris Pharmaceuticals Shareholders Back Key Proposals and Directors Xeris presents data on SONICS study on effects of levoketoconazole on CS Xeris announces XeriSol data formulated once-weekly SC levothyroxine PremiumThe FlyXeris Biopharma initiated with an Outperform at Oppenheimer Acelyrin price target raised to $13 from $11 at Wells Fargo Biotech Alert: Searches spiking for these stocks today